ALT Next Earnings Date Notes

— Altimmune (ticker: ALT) is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for obesity & liver diseases, particularly metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH). Its lead candidate is pemvidutide, a dual GLP-1/glucagon receptor agonist being evaluated for both obesity & MASH, targeting crucial unmet needs in these large markets. As you listen to the next earnings call, core business metrics to monitor include clinical trial updates (especially topline Phase 2 results for pemvidutide in obesity & MASH), safety & efficacy data, timelines for advancing to late-stage trials, and cash runway. Watch for guidance about potential regulatory pathways, partnership opportunities, & management commentary on competitive positioning versus other metabolic drug developers. R&D expenses, burn rate, & cash on hand (as per the latest balance sheet) are key to understanding Altimmune’s financial flexibility as it pursues pivotal trials. Ultimately, milestones related to late-phase trial launches or results, plus strategic collaborations, are critical for evaluating long-term value creation & the probability of commercial success in highly dynamic obesity and liver disease markets. The next projected earnings date for ALT is 8/11/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

ALT Next Earnings Date FAQ

On this page we presented the ALT Next Earnings Date information for Altimmune along with recent past earnings dates. For Q1 of 2026, ALT reported earnings of -0.180/share, with the earnings report taking place on 5/13/2026. For Q4 of 2025, ALT reported earnings of -0.270/share, with the earnings report taking place on 3/5/2026. For Q3 of 2025, ALT reported earnings of -0.210/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, ALT reported earnings of -0.270/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, ALT reported earnings of -0.260/share, with the earnings report taking place on 5/13/2025. Based on these past earnings dates, the projected next earnings date for ALT is 8/11/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Altimmune. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Altimmune shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Altimmune next earnings dates as well as any other stock out there in our coverage universe, to see when the next ALT earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ALT's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ALT next earnings date.